Breast cancer. Malignant neoplasm of breast
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: A definitive diagnosis of cancer and a history of cancer based on medical records. Exposure to stage one, two or three diseases and completion of treatment courses (Breast Removal Surgery, Chemotherapy, Radiotherapy) at least in the last 6 months Menopause Body mass index more than 25 kg/m2 Body fat more than 30%
Exclusion criteria
Exclusion criteria: Cardiovascular disease Diabetes Thyroid diseases smoking
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum levels of IL-8. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method.;Serum levels of Leptin. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method.;Serum levels of Adiponectin. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method.;Serum levels of IGF-1. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method.;Serum levels of IGFBP-3. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method.;Serum levels of TAC. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method.;Serum levels of MDA. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method.;Serum levels of 8-OHdG. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method. | — |
Countries
Iran (Islamic Republic of)
Contacts
University of Tehran